Pretreatment DPYD Genotyping Reduces the Risk of Capecitabine-associated Severe Toxicities: a Prospective Validation Study

Autor: Stavraka, C., Pouptsis, A., Okonta, L., De Souza, K., Marinaki, A., Karapanagiotou, E., Papadatos-Pastos, D., Mansi, J.
Zdroj: In Clinical Oncology July 2019 31(7):e114-e115
Databáze: ScienceDirect